AmeriFlex Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.8K Buy
586
+19
+3% +$2.85K 0.04% 353
2026
Q1
$86.6K Buy
567
+11
+2% +$1.69K 0.04% 314
2025
Q4
$76.6K Buy
556
+460
+479% +$60.2K 0.04% 338
2025
Q3
$12.3K Buy
+96
New +$11.7K ﹤0.01% 736

Other funds holding NVS

AmeriFlex Group's NVS Position: Q2 2026 in Review

AmeriFlex Group increased its Novartis (NVS) stake by 3.4% in Q2 2026, buying an estimated $2.85K and bringing the position to 586 shares worth $91.8K. The position accounts for 0.04% of the portfolio, ranked #353.

AmeriFlex Group first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • AmeriFlex Group held 586 shares of Novartis worth $91.8K as of Q2 2026.
  • AmeriFlex Group bought 19 Novartis shares in Q2 2026, an estimated $2.85K.
  • Novartis made up 0.04% of AmeriFlex Group's portfolio in Q2 2026, its #353 holding.
  • AmeriFlex Group first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.